Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa
Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa
About this item
Full title
Author / Creator
Publisher
Los Angeles, CA: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
Los Angeles, CA: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Introduction
Andexanet alfa (andexanet) is an approved antidote used to reverse the bleeding effects of Direct Oral Anticoagulant (Direct-Xa agents) agents because it reverses anti-Xa activity. Unfractionated heparin (UFH) and low molecular weight heparins (LMWHs) exhibit anti-Xa activity. The purpose is to investigate the neutralization of UFH...
Alternative Titles
Full title
Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_898573021cb94fc8992380467d649964
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_898573021cb94fc8992380467d649964
Other Identifiers
ISSN
1076-0296
E-ISSN
1938-2723
DOI
10.1177/10760296221099934
